A Phase 1 Dose Escalation Study of Oral VX-708 in Healthy Participants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending doses of VX-708 in healthy participants.
Epistemonikos ID: 92da55ac3f9ca8ce89ddb4386584fe6e31993a78
First added on: May 13, 2024